Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 200

1.

A family of sulfonylurea receptors determines the pharmacological properties of ATP-sensitive K+ channels.

Inagaki N, Gonoi T, Clement JP, Wang CZ, Aguilar-Bryan L, Bryan J, Seino S.

Neuron. 1996 May;16(5):1011-7.

2.

Putative subunits of the rat mesangial KATP: a type 2B sulfonylurea receptor and an inwardly rectifying K+ channel.

Szamosfalvi B, Cortes P, Alviani R, Asano K, Riser BL, Zasuwa G, Yee J.

Kidney Int. 2002 May;61(5):1739-49.

3.
4.
5.

A view of sur/KIR6.X, KATP channels.

Babenko AP, Aguilar-Bryan L, Bryan J.

Annu Rev Physiol. 1998;60:667-87. Review.

PMID:
9558481
6.
7.

A transmembrane domain of the sulfonylurea receptor mediates activation of ATP-sensitive K(+) channels by K(+) channel openers.

D'hahan N, Jacquet H, Moreau C, Catty P, Vivaudou M.

Mol Pharmacol. 1999 Aug;56(2):308-15.

8.

Sulfonylurea receptor-dependent and -independent pathways mediate vasodilation induced by ATP-sensitive K+ channel openers.

Adebiyi A, McNally EM, Jaggar JH.

Mol Pharmacol. 2008 Sep;74(3):736-43. doi: 10.1124/mol.108.048165. Epub 2008 May 29.

9.

SUR, ABC proteins targeted by KATP channel openers.

Moreau C, Prost AL, Dérand R, Vivaudou M.

J Mol Cell Cardiol. 2005 Jun;38(6):951-63. Epub 2005 Feb 19. Review.

PMID:
15910880
10.

Stoichiometry of sulfonylurea-induced ATP-sensitive potassium channel closure.

Dörschner H, Brekardin E, Uhde I, Schwanstecher C, Schwanstecher M.

Mol Pharmacol. 1999 Jun;55(6):1060-6.

11.

Altered functional properties of KATP channel conferred by a novel splice variant of SUR1.

Sakura H, Trapp S, Liss B, Ashcroft FM.

J Physiol. 1999 Dec 1;521 Pt 2:337-50.

12.

A novel sulfonylurea receptor forms with BIR (Kir6.2) a smooth muscle type ATP-sensitive K+ channel.

Isomoto S, Kondo C, Yamada M, Matsumoto S, Higashiguchi O, Horio Y, Matsuzawa Y, Kurachi Y.

J Biol Chem. 1996 Oct 4;271(40):24321-4.

13.

Characterization of K(ATP)-channels in rat basilar and middle cerebral arteries: studies of vasomotor responses and mRNA expression.

Jansen-Olesen I, Mortensen CH, El-Bariaki N, Ploug KB.

Eur J Pharmacol. 2005 Oct 31;523(1-3):109-18. Epub 2005 Oct 13.

PMID:
16226739
14.

Potassium channel openers require ATP to bind to and act through sulfonylurea receptors.

Schwanstecher M, Sieverding C, Dörschner H, Gross I, Aguilar-Bryan L, Schwanstecher C, Bryan J.

EMBO J. 1998 Oct 1;17(19):5529-35.

15.

[Activation of ATP-sensitive K+ channels by ADP and K+ channel openers: homology model of sulfonylurea receptor carboxyl-termini].

Fujita A, Matsuoka T, Matsushita K, Kurachi Y.

Nihon Yakurigaku Zasshi. 2001 Sep;118(3):177-86. Review. Japanese.

PMID:
11577458
16.

The molecular basis of the specificity of action of K(ATP) channel openers.

Moreau C, Jacquet H, Prost AL, D'hahan N, Vivaudou M.

EMBO J. 2000 Dec 15;19(24):6644-51.

18.

Interaction of a novel dihydropyridine K+ channel opener, A-312110, with recombinant sulphonylurea receptors and KATP channels: comparison with the cyanoguanidine P1075.

Felsch H, Lange U, Hambrock A, Löffler-Walz C, Russ U, Carroll WA, Gopalakrishnan M, Quast U.

Br J Pharmacol. 2004 Apr;141(7):1098-105. Epub 2004 Mar 15.

19.

Coexpression with the inward rectifier K(+) channel Kir6.1 increases the affinity of the vascular sulfonylurea receptor SUR2B for glibenclamide.

Russ U, Hambrock A, Artunc F, Löffler-Walz C, Horio Y, Kurachi Y, Quast U.

Mol Pharmacol. 1999 Nov;56(5):955-61.

20.

Supplemental Content

Support Center